Kunpeng Li
Lanzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Single-cell and spatial transcriptomics identify CAPG as a key driver of cisplatin resistance in bladder cancer.
Journal: Functional & integrative genomics
Published: March 05, 2026
Current perspectives and trends on the role of mitochondria in renal ischemia-reperfusion injury from 2005 to 2024: a bibliometric analysis and literature review.
Journal: Frontiers in physiology
Published: October 03, 2025
TPI1 enhances gemcitabine resistance in bladder cancer by promoting autophagy through activating Beclin-1.
Journal: Cell death & disease
Published: July 01, 2025
Targeting PSMB5-induced PANoptosis in bladder cancer: multi-omics insights and TCM candidate discovery.
Journal: Frontiers in immunology
Published: June 30, 2025
TPI1 promotes p53 ubiquitination in bladder cancer by recruiting AKT to enhance MDM2 phosphorylation.
Journal: Pharmacological research
Published: January 21, 2025
The MCM6-c-Myc positive feedback loop mediates bladder cancer progression and cisplatin resistance.
Journal: International journal of biological macromolecules
Published: October 21, 2024
Comment on: "Open versus robot‑assisted partial nephrectomy for highly complex renal masses: a meta‑analysis of perioperative and functional outcomes".
Journal: Journal of robotic surgery
Published: September 15, 2024
Macroscale Superlubrication Achieved with Shear-Thinning Semisolid Lubricants.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: August 19, 2024
MELATONIN ATTENUATES RENAL ISCHEMIA-REPERFUSION INJURY BY REGULATING MITOCHONDRIAL DYNAMICS AND AUTOPHAGY THROUGH AMPK/DRP1.
Journal: Shock (Augusta, Ga.)
Published: May 07, 2024
Which surgical approach is more favorable for pheochromocytoma of different sizes (< 6 cm vs. ≥ 6 cm)? A single retrospective center experience.
Journal: World journal of surgical oncology
Published: June 15, 2023
Last Updated: 09/26/2026